Prices of 56 drugs to come down; NPPA fixes ceiling rates
Prices may come down of 56 important medicines used in treatment of cancer, diabetes, bacterial infections and high blood pressure, with the government fixing their ceiling prices under the drug pricing control mechanism.
Jun 06, 2016, 17:51 PM IST
Price cap in 530 essential medicines, including 47 for cancer
The National Pharmaceutical Pricing Authority (NPPA) has fixed the ceiling prices for 530 essential medicines, including 47 for cancer and 22 for HIV, Lok Sabha was informed today.
Dec 22, 2015, 21:35 PM IST
Government forms committee to review drug pricing policy
The government has formed an inter-ministerial committee to review the Drug Price Control Order (DPCO) 2013, following the Supreme Court verdict this year that termed the drug pricing policy as irrational and unreasonable.
Nov 01, 2015, 15:16 PM IST
Prices of folic acid, multivitamins likely to rise
The prices of supplement medicines like folic acid or multivitamins are seen rising significantly, as costly imports are forcing the domestic manufacturers to the wall
Oct 19, 2015, 09:20 AM IST
NPPA gives deadline to drug cos for online data registration
Drug price regulator NPPA has given pharma firms time till Friday to register for online database with 19 out of top 100 drug makers yet to respond after repeated reminders.
Jun 03, 2015, 22:55 PM IST
High Court stays Rs 1.35 cr demand slapped on Novartis by NPPA
Novartis, in its plea, claimed that the government by a June 14, 2013 notification had revised the price of its drug, Regestrone, used for regulating women's menstrual cycle.
Jun 01, 2015, 17:15 PM IST
NPPA warns drug cos over non-registration with online database
With just 41 out of top 100 pharma firms responding to its direction to register for online database, drug price regulator NPPA has warned to take action if the rest of the companies did not comply with its order immediately.
May 04, 2015, 21:59 PM IST
NPPA yet to recover Rs 3,680 cr for drug price overcharging
Drug price regulator NPPA is still to recover Rs 3,680.43 crore from various pharmaceutical companies for overcharging, while almost 95 per cent of the amount is under litigation.
Mar 15, 2015, 13:40 PM IST
Patented drugs details sought from drug makers for price negotiation
In its drive to fix prices of patented drugs, national drug price regulator NPPA has sought complete details of such medicines sold in the Indian market from drug makers.
Jan 29, 2015, 23:04 PM IST
Govt forms committee for revising List of Essential Medicines
The government formed core committee, comprising drug price regulator NPPA and Department of Pharmaceutical, for revision of National List of Essential Medicines is yet to submit its report.
Dec 19, 2014, 15:59 PM IST
Pharmaceuticals dept considering price monitoring cells
The Department of Pharmaceuticals is considering setting up price monitoring cells in all states to provide technical assistance to drug controllers and the National Pharmaceutical Pricing Authority (NPPA).
Dec 02, 2014, 15:35 PM IST
NPPA slaps Rs 300-crore penalty on Novartis for overcharging
Drug major Novartis has been slapped with a Rs 300-crore penalty by drug regulator NPPA for overcharging consumers on sale of Voveran, its best-selling painkiller medicine.
Oct 13, 2014, 23:00 PM IST
Govt strips pharma pricing regulator's powers to cap non-essential drug prices
The government has stripped drug pricing authority NPPA of powers to cap prices of non- essential drugs after its recent order triggered industry protests.
Sep 23, 2014, 11:22 AM IST
Govt developing online database to monitor drug prices
The government is developing an online database system that will require pharmaceutical companies to submit information in order to enable NPPA to control drug price effectively.
Aug 05, 2014, 17:37 PM IST
Delhi HC refuses to stay order fixing prices of over 100 drugs
The Delhi High Court on Friday refused to stay the National Pharmaceutical Pricing Authority order fixing prices of over 100 non- scheduled drugs.
Aug 01, 2014, 13:41 PM IST
Price cut: Drug makers' profitability may come under pressure
Among MNCs, Sanofi Aventis, Abbott and Pfizer are also likely to be affected owing to their sizeable share exposure on anti-diabetic segment and Indian market in general.
Jul 20, 2014, 12:42 PM IST
NPPA order may not impact much, seeking legal advice: Reddy's
The recent National Pharmaceutical Pricing Authority (NPPA) order bringing in some more medicines under control may not have much impact on city-based drug maker Dr Reddy's Laboratories in terms of product pricing, according to a senior company official.
Jul 16, 2014, 16:25 PM IST
India caps prices of 108 more medicines
Controlling the prices of drugs will help provide affordable medicine for the 70 percent of the population who live on less than $2 a day.
Jul 14, 2014, 13:39 PM IST
